Literature DB >> 23794244

Transoral partial epiglottidectomy to treat dysphagia in post-treatment head and neck cancer patients: a preliminary report.

Nausheen Jamal1, Andrew Erman, Dinesh K Chhetri.   

Abstract

OBJECTIVES: To determine symptoms and findings in patients with dysphagia related to epiglottic dysfunction. To analyze outcomes in patients who underwent partial epiglottidectomy due to dysphagia related to epiglottic dysfunction. STUDY
DESIGN: Review and analysis of clinical data obtained as part of the diagnosis and treatment of patients with dysphagia related to epiglottic dysfunction.
METHODS: A retrospective review was performed of all post-treatment head and neck cancer patients who underwent epiglottidectomy at a single tertiary care referral center. Objective pre- and postprocedure swallow findings, endoscopic evaluation, and subjective improvement based on patient self-reports were reviewed.
RESULTS: Seven patients were identified based on endoscopic evaluation and modified barium swallow study (MBSS) as having epiglottic pathology leading to dysphagia. Specific anatomic and functional findings included thickening of the epiglottis, absence of epiglottic deflection, vallecular bolus retention during and after the swallow, and bolus backflow from the pharynx to the oral or nasal cavity. Partial epiglottidectomy was performed in these patients. Postoperative MBSS was analyzed for changes in swallow efficiency and safety. Nearly all patients demonstrated improved pharyngeal bolus passage with little to no added swallowing morbidity.
CONCLUSIONS: Preliminary findings suggest a role for partial epiglottidectomy in post-treatment head and neck cancer patients with swallowing disorders. Ideal candidates have intact tongue base contraction and poor retroflexion of the epiglottis, which results in bolus obstruction at the level of the valleculae. Partial epiglottic resection enables improved bolus passage in the pharyngeal phase. Minimal postoperative morbidity occurs in the appropriately selected patient.
© 2013 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Dysphagia; chemotherapy; epiglottectomy; epiglottidectomy; head and neck cancer; quality of life; radiation

Mesh:

Year:  2013        PMID: 23794244      PMCID: PMC3841234          DOI: 10.1002/lary.24278

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  25 in total

1.  Laser epiglottectomy: endoscopic technique and indications.

Authors:  S M Zeitels; C W Vaughan; G F Domanowski; N S Fuleihan; G T Simpson
Journal:  Otolaryngol Head Neck Surg       Date:  1990-09       Impact factor: 3.497

2.  Retroverted epiglottis presenting as a variant of globus pharyngeus.

Authors:  F O Agada; A P Coatesworth; A R H Grace
Journal:  J Laryngol Otol       Date:  2007-01-04       Impact factor: 1.469

3.  The Function of the Epiglottis in Deglutition and Phonation.

Authors:  G L Walton
Journal:  J Physiol       Date:  1878-09-25       Impact factor: 5.182

4.  A penetration-aspiration scale.

Authors:  J C Rosenbek; J A Robbins; E B Roecker; J L Coyle; J L Wood
Journal:  Dysphagia       Date:  1996       Impact factor: 3.438

5.  Postnatal descent of the epiglottis in man. A preliminary report.

Authors:  C T Sasaki; P A Levine; J T Laitman; E S Crelin
Journal:  Arch Otolaryngol       Date:  1977-03

6.  Laser partial epiglottidectomy as a treatment for obstructive sleep apnea and laryngomalacia.

Authors:  A Golz; D Goldenberg; S T Westerman; F J Catalfumo; A Netzer; L M Westerman; H Z Joachims
Journal:  Ann Otol Rhinol Laryngol       Date:  2000-12       Impact factor: 1.547

7.  Impact of dysphagia on quality of life after treatment of head-and-neck cancer.

Authors:  Nam P Nguyen; Cheryl Frank; Candace C Moltz; Paul Vos; Herbert J Smith; Ulf Karlsson; Suresh Dutta; Allan Midyett; Jessica Barloon; Sabah Sallah
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-03-01       Impact factor: 7.038

8.  Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy.

Authors:  Johannes A Langendijk; Patricia Doornaert; Irma M Verdonck-de Leeuw; Charles R Leemans; Neil K Aaronson; Ben J Slotman
Journal:  J Clin Oncol       Date:  2008-08-01       Impact factor: 44.544

Review 9.  Practical considerations in reducing swallowing dysfunction following concurrent chemoradiotherapy with intensity-modulated radiotherapy for head and neck cancer.

Authors:  Sukhjeet S Batth; Jimmy J Caudell; Allen M Chen
Journal:  Head Neck       Date:  2013-03-18       Impact factor: 3.147

10.  CO2 laser treatment of supraglottic cancer.

Authors:  Gaetano Motta; Erik Esposito; Domenico Testa; Renata Iovine; Sergio Motta
Journal:  Head Neck       Date:  2004-05       Impact factor: 3.147

View more
  1 in total

1.  Ultrasound-guided microwave ablation in the treatment of early-stage tongue cancer.

Authors:  Jianquan Yang; Wen Guo; Rong Huang; Zhengmin Xu; Chunyang Zhou; Man Lu
Journal:  Front Oncol       Date:  2022-08-30       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.